Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shlipak

Showing results (11-20 of 736) with videos related to

Pageof 74
Sort By:
JAMA|July 13, 2001
Alcohol use as a prognostic factor following myocardial infarctionJ G Wiese, M Shlipak
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2016
Kidney Disease, Income, and Life ExpectancyJoshua Lang, Michael G Shlipak
Nature Reviews. Nephrology|May 13, 2015
Risk factors: Individual assessment of CKD risk in HIV-positive patientsRebecca Scherzer, Michael G Shlipak
Journal of the American Society of Nephrology : JASN|November 11, 2005
Observational research databases in renal diseaseMichael Shlipak, Catherine Stehman-Breen
Hypertension (Dallas, Tex. : 1979)|August 30, 2008
Hypertension in children with chronic kidney disease: a call to actionCarmen A Peralta, Michael G Shlipak
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 20, 2024
The New Cardiovascular-Kidney-Metabolic (CKM) Syndrome: An Opportunity for CKD Detection and Treatment in Primary CareSara-Megumi Rumrill, Michael G Shlipak
Journal of the American Geriatrics Society|September 24, 2022
Age-adapted eGFR thresholds underestimate the risks beyond kidney failure associated with CKD in older populationsJennifer S Lees, Michael G Shlipak
Clinical Chemistry|February 4, 2025
Glomerular Filtration Rate (GFR) Estimation with Cystatin C-Past, Present, and FutureAmy B Karger, Michael G Shlipak
Circulation|September 24, 2004
The clinical challenge of cardiorenal syndromeMichael G Shlipak, Barry M Massie
Nature Reviews. Nephrology|June 12, 2013
Biomarkers for incident CKD: a new framework for interpreting the literatureMichael G Shlipak, Erica C Day
Pageof 74

Showing results (11-20 of 736) with videos related to

Sort By:
Pageof 74
JAMA|July 13, 2001
Alcohol use as a prognostic factor following myocardial infarctionJ G Wiese, M Shlipak
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2016
Kidney Disease, Income, and Life ExpectancyJoshua Lang, Michael G Shlipak
Nature Reviews. Nephrology|May 13, 2015
Risk factors: Individual assessment of CKD risk in HIV-positive patientsRebecca Scherzer, Michael G Shlipak
Journal of the American Society of Nephrology : JASN|November 11, 2005
Observational research databases in renal diseaseMichael Shlipak, Catherine Stehman-Breen
Hypertension (Dallas, Tex. : 1979)|August 30, 2008
Hypertension in children with chronic kidney disease: a call to actionCarmen A Peralta, Michael G Shlipak
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 20, 2024
The New Cardiovascular-Kidney-Metabolic (CKM) Syndrome: An Opportunity for CKD Detection and Treatment in Primary CareSara-Megumi Rumrill, Michael G Shlipak
Journal of the American Geriatrics Society|September 24, 2022
Age-adapted eGFR thresholds underestimate the risks beyond kidney failure associated with CKD in older populationsJennifer S Lees, Michael G Shlipak
Clinical Chemistry|February 4, 2025
Glomerular Filtration Rate (GFR) Estimation with Cystatin C-Past, Present, and FutureAmy B Karger, Michael G Shlipak
Circulation|September 24, 2004
The clinical challenge of cardiorenal syndromeMichael G Shlipak, Barry M Massie
Nature Reviews. Nephrology|June 12, 2013
Biomarkers for incident CKD: a new framework for interpreting the literatureMichael G Shlipak, Erica C Day
Pageof 74